These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6172214)

  • 1. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.
    Epstein LB; Marcus SG
    Cancer Chemother Pharmacol; 1981; 6(3):273-7. PubMed ID: 6172214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further experience in testing the sensitivity of human ovarian carcinoma cells to interferon in an in vitro semisolid agar culture system: comparison of solid and ascitic forms of the tumor.
    Epstein LB; Shen JT; Abele JS; Reese CC
    Prog Clin Biol Res; 1980; 48():277-90. PubMed ID: 6163159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.
    Epstein LB; Shen JT; Abele JS; Reese CC
    Ann N Y Acad Sci; 1980; 350():228-44. PubMed ID: 6165278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
    Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
    J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
    Peri G; Polentarutti N; Sessa C; Mangioni C; Mantovani A
    Int J Cancer; 1981 Aug; 28(2):143-52. PubMed ID: 6172388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of clonogenic cells of human ovarian ascitic cancer to antitumor drugs.
    Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV
    Arch Geschwulstforsch; 1988; 58(2):99-104. PubMed ID: 3377653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fibroblast, lymphoid, and myeloid interferons on human tumor colony formation in vitro.
    Bradley EC; Ruscetti FW
    Cancer Res; 1981 Jan; 41(1):244-9. PubMed ID: 6160905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
    Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous soft agar cloning of ascites and solid tumor specimens from patients with ovarian cancer.
    Sridhar KS; Ohnuma T; Plasse TF; Holland JF
    Cancer; 1988 Oct; 62(8):1577-81. PubMed ID: 3167771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of tumor colony development over time in soft-agar culture.
    Kirkels WJ; Pelgrim OE; Hoogenboom AM; Aalders MW; Debruyne FM; Vooijs GP; Herman CJ
    Int J Cancer; 1983 Oct; 32(4):399-406. PubMed ID: 6194124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth patterns and hormonal sensitivity of primary tumor, abdominal metastasis and ascitic fluid from human epithelial ovarian carcinomas in the tumor colony-forming assay.
    Runge HM; Neumann HA; Bauknecht T; Pfleiderer A
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):691-6. PubMed ID: 3743604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
    Fuller AF; Krane IM; Budzik GP; Donahoe PK
    Gynecol Oncol; 1985 Oct; 22(2):135-48. PubMed ID: 3932140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumor cloning: feasibility and clinical correlations.
    Von Hoff DD; Cowan J; Harris G; Reisdorf G
    Cancer Chemother Pharmacol; 1981; 6(3):265-71. PubMed ID: 7318147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of drug sensitivity testing in soft agar for clinical management of patients with ovarian carcinoma.
    Arbuck SG; Pavelic ZP; Piver MS; Slocum HK; Malfetano J; Gamarra M; Rustum YM
    Obstet Gynecol; 1985 Jul; 66(1):115-20. PubMed ID: 3892385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fibroblast interferon on colony tumor growth of miscellaneous solid human tumors.
    Schlag P; Wolfrum J; Schreml W; Herfarth C
    Klin Wochenschr; 1982 Dec; 60(23):1455-9. PubMed ID: 7154619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interferon on the growth of primary ovarian carcinoma cells in a semi-solid agar system: comparison with clinical effects of interferon therapy.
    Ling P; Einhorn S; Anjegård IM; Brenning G; Einhorn N; Strander H
    Med Oncol Tumor Pharmacother; 1987; 4(2):81-6. PubMed ID: 3669781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.
    Alberts DS; Chen HS; Salmon SE; Surwit EA; Young L; Moon TE; Meyskens FL
    Cancer Chemother Pharmacol; 1981; 6(3):279-85. PubMed ID: 6172215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonogenic cell assay for carcinoma of the lung.
    Kanzawa F; Hoshi A; Shimizu E; Saijo N; Miyazawa N; Shimabukuro Z
    Gan; 1984 Jan; 75(1):81-8. PubMed ID: 6327452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.